NewsBenzinga리어링크 파트너스, 뉴로페이스 투자의견 ‘시장수익률’로 하향 조정 및 목표주가 7달러 제시 리어링크 파트너스, 뉴로페이스 투자의견 ‘시장수익률’로 하향 조정 및 목표주가 7달러 제시 Benzinga 2026.11.13 12:37 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report